Search results

The National Deuteration Facility offers access to deuterated molecules prepared by both in vivo biodeuteration and chemical deuteration techniques.

By submitting a proposal for Merit Access to ANSTO’s Biosciences, Centre for Accelerator Science, Isotope Tracing, Nuclear Stewardship or the Vivarium capabilities, you are agreeing to the following Terms and Conditions. These Terms and Conditions apply to external merit researchers, scientific collaborators and partners unless there is a specific agreement in place between ANSTO and the home institution of the Principal Investigator.

ANSTO is a unique national science organisation that began operating under its predecessor The Australian Atomic Energy Commission (AAEC) 70 years ago.

A site for the National Radioactive Waste Management Facility has been acquired, with the new facility to be built near the town of Kimba on the South Australian Eyre Peninsula. 

ANSTO has safely managed its radioactive waste for over 60 years. Waste is managed in accordance with national and international standards.

The Australian Centre for Neutron Scattering (ACNS) is a major research facility for neutron science that comprises a suite of neutron instruments with a range of techniques for scientific investigations in physics, chemistry, materials science, medicine and environmental science among other fields.

2025 ANSTO Work Experience Program will be open for applications in the new year.

Beamtime guide on the Far infrared beamline at the Australian Synchrotron.

A world-class national research facility that uses accelerator technology to produce a powerful source of light-X rays and infrared radiation a million times brighter than the sun.

Science and medical experts meet in Adelaide to discuss great potential of particle therapy in Australia

ANSTO has a role in the global monitoring system on behalf of Australia to ensure non-proliferation of weapons and that nuclear technology is only used for peaceful purposes.

The National Deuteration Facility offers the facilities and expertise to produce molecules where all or part of the molecular hydrogen is replaced with deuterium. This enables complex investigations of the relationship between the structure of molecules and their function using neutron scattering and other techniques.

The newly built Medicines Manufacturing Innovation Centre (MMIC), co-located at the Australian Synchrotron at Clayton, was officially opened on Wednesday by the Victorian Deputy Premier and Minister for Medical Research the Hon Ben Carroll.

ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.

The Australian Synchrotron has an on-site Guesthouse for users and AS guests.

ANSTO today welcomed a significant Federal Government funding allocation to further safeguard the production of life-saving nuclear medicines in Australia.